Home/Filings/4/0001179110-15-012105
4//SEC Filing

ALDER BIOPHARMACEUTICALS INC 4

Accession 0001179110-15-012105

CIK 0001423824operating

Filed

Aug 12, 8:00 PM ET

Accepted

Aug 13, 7:50 PM ET

Size

37.0 KB

Accession

0001179110-15-012105

Insider Transaction Report

Form 4
Period: 2015-08-11
Transactions
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
Transactions
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
Transactions
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
Transactions
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
Transactions
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
Transactions
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
Transactions
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
Transactions
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-12+3,3166,980 total
  • Other

    Common Stock

    2015-08-15+2,5175,299 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Sale

    Common Stock

    2015-08-12$40.03/sh97,109$3,887,4091,812,016 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+1,2592,651 total
  • Other

    Common Stock

    2015-08-12+2,1184,458 total
  • Sale

    Common Stock

    2015-08-11$40.40/sh115,358$4,660,7631,909,125 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-121,795,75216,264 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4216,306 total(indirect: See Footnote)
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
  • Other

    Common Stock

    2015-08-12+4,1158,662 total
Footnotes (16)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.90 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F10]Represents the receipt of shares by Bayless of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F11]Represents the receipt of shares by Domenik of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F12]Represents the receipt of shares by Kimzey of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F13]Represents the receipt of shares by McLean of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F14]Represents the receipt of shares by Oxaal of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F15]Represents the receipt of shares by Schuele of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F16]Represents the receipt of shares by Sturiale of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F2]Total Common Shares of 1,909,125 represents 46 shares owned directly by SRB Associates IX L.P. ("SRBAIX"), 1,860,948 shares owned directly by Sevin Rosen Fund IX L.P. ("SRFIX"), 48,131 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRFIX AFF"). John V. Jaggers ("Jaggers"), Jon W. Bayless ("Bayless") Stephen L. Domenik, ("Domenik"), Jackie R.Kimzey ("Kimzey") David J. McLean ("McLean"), John T. Oxaal ("Oxaal"), Alan R. Schuele ("Schuele") and Nicholas G. Sturiale ("Sturiale") are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.26 to $40.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities And Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F4]Total Common Shares of 1,812,016 represents 46 shares owned directly by SRBAIX, 1,765,877 shares owned directly by SRFIX and 46,093 shares owned directly by SRFIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  • [F5]Represents a pro-rata in-kind distribution, without additional consideration, of 1,750,000 shares of Common Stock of the Issuer by SRFIX and 45,752 shares of Common Stock of the Issuer by SRIXAFF.
  • [F6]Total Common Shares of 16,264 represents 46 shares owned directly by SRBAIX, 15,877 shares owned directly by SRFIX and 341 shares owned directly by SRIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  • [F7]Represents the receipt of shares by SRBAIX of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.
  • [F8]Total Common Shares of 16,306 represents 88 shares owned directly by SRBAIX, 15,877 shares owned directly by SRFIX and 341 shares owned directly by SRIX AFF. Jaggers, Bayless, Domenik, Kimzey, McLean, Oxaal, Schuele and Sturiale are members of the general partner of SRBAIX, the general partner of SRFIX and SRIX AFF, and as members are deemed to have shared voting and dispositive power of the shares and disclaim beneficial ownership of these shares except to the extent of his proportionate interest in these shares.
  • [F9]Represents the receipt of shares by Jaggers of Common Stock of the Issuer by virtue of the pro rata in-kind distribution described in footnote (5) above.

Issuer

ALDER BIOPHARMACEUTICALS INC

CIK 0001423824

Entity typeoperating

Related Parties

1
  • filerCIK 0001423824

Filing Metadata

Form type
4
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 7:50 PM ET
Size
37.0 KB